Ati cautat: lipsa unor medicamente
Protocol terapeutic: A16AX09 – GLYCEROLI PHENYLBUTYRAS (actualizat APRILIE 2022 conform ordin MS/CNAS NR 1206/233/2022)
Protocol terapeutic: L01XC11-17 – DCI NIVOLUMAB + DCI IPILIMUMAB (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: D11AH05 – DCI DUPILUMABUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: A16AB03 – DCI AGALSIDASUM ALFA (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L04AA25-SHUa – DCI ECULIZUMABUM (actualizat MARTIE 2022 conform ordin MS/CNAS NR 702/133/2022)
Protocol terapeutic: L04AA25-HPN – DCI ECULIZUMABUM (actualizat MARTIE 2022 conform ordin MS/CNAS NR 702/133/2022)
Protocol terapeutic: L01XE54 – DCI GILTERITINIB (actualizat MARTIE 2022 conform ordin MS/CNAS NR 702/133/2022)
Protocol terapeutic: N07XX11 – DCI PITOLISANTUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Iohannis a solicitat reexaminarea legii care completeaza atributiile ANMDM
Consiliul Concurentei: Amenzi de 71 milioane euro pe piata imunoglobulinelor